The baseline time span for this database is (publication years)
1998-February 29, 2008 from the first bimonthly update (a 10-year + 2-month
period). The resulting database contained 4,745 (10 years) and 1,354 (2
years) papers; 14,480 authors; 102 nations; 665 journals; and 3,484
institutions.
Interviews, first-person essays, and profiles about
people in a wide variety of fields which pertain to
this special topic of Human Papillomavirus.
OVERVIEW
The US Centers for Disease Control and Prevention states that there are 40
types of human papillomavirus (HPV) that can cause genital infections in
both men and women. The CDC's
statistics indicate that as many as 20 million
Americans currently have HPV, that 6.2 million will be newly infected
annually, and that at least 50% of sexually active people will contract
some form of HPV at some point.
According to the World Health Organization, in 2005
there were 265,884 new cases of HPV diagnosed in Asia, 78,897 new cases
in Africa, 59,931 new cases in Europe, 86,532 new cases in the Americas,
and 2,002 new cases in Oceania.
This month, Sciencewatch.com examines the most-cited research on
HPV over the past decade and over the past two years, using the title
keywords "HPV," "human papilloma virus," and "human papillomavirus."
The literature on HPV over the past decade examines the role of HPV in the
development of cervical cancer, the epidemiology of types of HPV associated
with cervical cancer in various parts of the world, the use of HPV DNA to
test for cervical cancer, the use of HPV status in screening for cervical
cancer, and trials of different HPV vaccines in the prevention of cervical
cancer.
More than half of the 20 most-cited papers published in the past two years
deal with vaccines for HPV, including studies from the HPV Vaccine Study
Group, Proof Principle Study, FUTURE I Investigators, FUTURE II Study
Group, and the HPV PATRICIA Study Group. Other topics covered in these
papers include the prevalence of HPV among US women, the role of condoms in
the reduction of HPV risk, parental attitudes towards HPV vaccination, and
screening methods for cervical cancer.
Methodology: To construct this database, papers were
extracted based this search criteria:
•
Title: ("human papilloma virus" OR
"human papillomavirus" OR HPV)
•
Refined by: Document Type=( ARTICLE
OR REVIEW )
The baseline time span for this database is (publication years)
1998-February 29, 2008 from the first bimonthly update (a 10-year + 2-month
period). The resulting database contained 4,745 (10 years) and 1,354 (2
years) papers; 14,480 authors; 102 nations; 665 journals; and 3,484
institutions.
Rankings: Once the database was in place, it was used to
generate the lists of top 20 papers (two- and ten-year periods), authors,
journals, institutions, and nations, covering a time span of 1998-February
29, 2008 (second bimonthly period 2008).
The top 20 papers are ranked according to total cites. Rankings for author,
journal, institution, and country are listed in three ways: according to
total cites, total papers, and total cites/paper. The paper thresholds and
corresponding percentages used to determine scientist, institution,
country, and journal rankings according to total cites/paper, and total
papers respectively are as follows:
Entity
Authors
Institutions
Nations
Journals
Thresholds
15
42
7
2
Percentage:
1%
1%
50%
20%
Special Topic Keywords: human
papillomavirus, HPV, cervical cancer, epidemiology,
vaccines, p53 polymorphism, cervical neoplasia, human
papillomavirus DNA, cervical cancer screening,
genotyping HPV, safety trials, immunogenicity trials,
bivalent L1 virus-like particle vaccine, human
papillomavirus-16 vaccine, quadrivalent vaccine,
immunologic responses, condom use, risk of genital
human papillomavirus infection, liquid-based cytology,
parental cceptance, HPV-mediated cervical
carcinogenesis, HPV-associated skin disease.